CVS Health Statistics

Total Valuation

CVS Health has a market cap or net worth of GBP 61.95 billion. The enterprise value is 116.12 billion.

Market Cap	61.95B
Enterprise Value	116.12B

Important Dates

The next estimated earnings date is Thursday, May 1, 2025.

Earnings Date	May 1, 2025
Ex-Dividend Date	Apr 22, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-2.17%
Shares Change (QoQ)	+0.16%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.26B

Valuation Ratios

The trailing PE ratio is 16.81.

PE Ratio	16.81
Forward PE	n/a
PS Ratio	0.21
PB Ratio	1.02
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.88, with an EV/FCF ratio of 22.98.

EV / Earnings	31.51
EV / Sales	0.42
EV / EBITDA	9.88
EV / EBIT	19.27
EV / FCF	22.98

Financial Position

The company has a current ratio of 0.81, with a Debt / Equity ratio of 1.09.

Current Ratio	0.81
Quick Ratio	0.56
Debt / Equity	1.09
Debt / EBITDA	5.30
Debt / FCF	13.11
Interest Coverage	2.71

Financial Efficiency

Return on equity (ROE) is 6.02% and return on invested capital (ROIC) is 3.19%.

Return on Equity (ROE)	6.02%
Return on Assets (ROA)	1.99%
Return on Invested Capital (ROIC)	3.19%
Return on Capital Employed (ROCE)	4.76%
Revenue Per Employee	1.14M
Profits Per Employee	14,202
Employee Count	300,000
Asset Turnover	1.47
Inventory Turnover	17.79

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -3.22% in the last 52 weeks. The beta is 0.57, so CVS Health's price volatility has been lower than the market average.

Beta (5Y)	0.57
52-Week Price Change	-3.22%
50-Day Moving Average	66.43
200-Day Moving Average	58.91
Relative Strength Index (RSI)	44.16
Average Volume (20 Days)	18,680

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.76

Income Statement

In the last 12 months, CVS Health had revenue of GBP 296.07 billion and earned 3.69 billion in profits. Earnings per share was 2.92.

Revenue	296.07B
Gross Profit	39.34B
Operating Income	6.41B
Pretax Income	4.91B
Net Income	3.69B
EBITDA	10.08B
EBIT	6.41B
Earnings Per Share (EPS)	2.92

Full Income Statement

Balance Sheet

The company has 8.78 billion in cash and 66.23 billion in debt, giving a net cash position of -57.45 billion.

Cash & Cash Equivalents	8.78B
Total Debt	66.23B
Net Cash	-57.45B
Net Cash Per Share	n/a
Equity (Book Value)	60.49B
Book Value Per Share	47.90
Working Capital	-12.75B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.27 billion and capital expenditures -2.22 billion, giving a free cash flow of 5.05 billion.

Operating Cash Flow	7.27B
Capital Expenditures	-2.22B
Free Cash Flow	5.05B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 13.29%, with operating and profit margins of 2.16% and 1.24%.

Gross Margin	13.29%
Operating Margin	2.16%
Pretax Margin	1.66%
Profit Margin	1.24%
EBITDA Margin	3.40%
EBIT Margin	2.16%
FCF Margin	1.71%

Dividends & Yields

This stock pays an annual dividend of 2.06, which amounts to a dividend yield of 3.14%.

Dividend Per Share	2.06
Dividend Yield	3.14%
Dividend Growth (YoY)	1.64%
Years of Dividend Growth	3
Payout Ratio	73.10%
Buyback Yield	2.17%
Shareholder Yield	5.31%
Earnings Yield	5.95%
FCF Yield	8.16%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CVS Health has an Altman Z-Score of 2.11. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.11
Piotroski F-Score	n/a